Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol add-on treatment for schizophrenia
IRCT20180307038989N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Cilostazol add-on with Placebo add-on (2 arms). Primary endpoints: Cognitive function and schizophrenia symptoms and Introduction of an auxiliary drug with fewer complications. Started Apr 2018; status: completed.
02
Drugs
cilostazol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20180307038989N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180307038989N1.